Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2014
12/23/2014US8916159 Selenocysteine mediated hybrid antibody molecules
12/23/2014US8916133 Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives
12/23/2014US8916132 Benzimidazole-derived compounds use as markers in the case of neurodegenerative diseases
12/23/2014US8916131 Radiopharmaceutical composition
12/18/2014US20140371434 Radiotracer precursor for imaging of hypoxic tissue, radiotracer, and method for preparing the same
12/18/2014US20140369933 Fluorine-18 labeled hydrogen ion probes
12/18/2014US20140369932 Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging
12/18/2014US20140369931 Psma-binding agents and uses thereof
12/18/2014US20140369930 Cyclotides as immunosuppressive agents
12/18/2014US20140369929 Ligands to radiation-induced molecules
12/18/2014US20140369928 Automatic synthesizer apparatus for producing radiopharmaceutical tumor imaging agent Gallium-68-DOTATATE and method thereof
12/18/2014US20140369927 Camptothecin Conjugates of Anti-CD22 Antibodies for Treatment of B Cell Diseases
12/18/2014US20140369924 Synergistic anti-cd47 therapy for hematologic cancers
12/17/2014CN104208727A 一种新型肿瘤显像剂(99n0TC-HYNIC/EDDA-TMTP1的制备与应用 A new tumor imaging agent (Preparation and Application 99n0TC-HYNIC / EDDA-TMTP1 of
12/17/2014CN103120640B 一种栓塞剂及其制备方法 One kind of embolic agents and its preparation method
12/17/2014CN103113354B 一种含peg化苄基三唑基的哒嗪酮类化合物及其制备方法和应用 PYRIDAZINONES its preparation method and application containing peg of benzyltriazole group
12/17/2014CN102858367B 抗原或药物递送复合物 Antigen or drug delivery complexes
12/16/2014US8913123 Needle shield positioning system and method
12/16/2014US8911732 Anti-mesothelin antibodies and immunoconjugates
12/16/2014US8911707 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
12/16/2014US8911706 Complex of bifunctional chelating agent and mannosyl human serum albumin
12/16/2014US8911705 Diagnostic substance and method for the analysis of metabolism processes in the brain
12/11/2014US20140364620 Radioactive fluorine-labeled compound
12/11/2014US20140364615 Indole derivatives
12/11/2014US20140363378 Self-assembling molecules that accumulate in acidic tumor microenvironments
12/11/2014US20140363377 Procaspase 8-mediated disease targeting
12/11/2014US20140363375 Activation of bioluminescence by structural complementation
12/11/2014US20140363374 Coupled identification and treatment of cancer
12/11/2014US20140363373 Method for combined imaging and treating organs and tissues
12/11/2014US20140363372 Methods for suppressing cancer by inhibition of tmcc3
12/11/2014US20140363371 Telodendrimers with enhanced drug delivery
12/10/2014CN104193820A 一种<sup>18</sup>F标记Cys-Annexin V的方法及其应用 One kind of <sup> 18 </ sup> F labeled Cys-Annexin V method and its application
12/10/2014CN102898470B 一类新型有机膦化合物及其制备方法和应用 A new class of organic phosphine compound and its preparation method and application
12/10/2014CN102861347B <sup>99m</sup>Tc标记半乳糖化RGD肿瘤诊断药物及制备方法 <Sup> 99m </ sup> Tc labeled RGD galactosed tumor diagnosis and drug preparation
12/10/2014CN102413844B 标记的分子成像剂、制备方法及使用方法 Labeled molecular imaging agent, preparation and method of use
12/10/2014CN102197036B 适于作为用于对淀粉样沉积物成像的化合物的前体的新的苯并呋喃 Compounds suitable as precursors for the imaging of amyloid deposits of new benzofuran
12/10/2014CN102123739B 用于蛋白质、肽和其他分子的改进的f-18标记方法和组合物 For proteins, peptides and other molecules improved f-18 labeling methods and compositions
12/10/2014CN102083427B 碳酸酐酶ix的抑制剂 Carbonic anhydrase inhibitors ix
12/10/2014CN101952433B 在疾病的诊断与治疗中的PTHrP,其亚型及其拮抗剂 PTHrP in the diagnosis and treatment of disease, and its subtypes and antagonists
12/10/2014CN101595083B [f-18]-标记的l-谷氨酸、[f-18]-标记的l-谷氨酰胺、它们的衍生物和应用以及制备方法 [F-18] - labeled l- glutamate, [f-18] - labeled l- glutamine, derivatives thereof, and preparation method and application
12/09/2014US8909325 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
12/09/2014US8907069 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
12/09/2014US8907058 PSMA binding ligand-linker conjugates and methods for using
12/09/2014US8906878 Myocardial perfusion imaging methods and compositions
12/09/2014US8906380 Fungal immunostimulatory compositions
12/09/2014US8906378 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
12/09/2014US8906377 Stably tethered structures of defined compositions with multiple functions or binding specificities
12/09/2014US8906344 F-18 radiolabeled compounds for diagnosing and monitoring kidney function
12/09/2014US8906343 PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded
12/09/2014US8906342 Compositions against cancer antigen LIV-1 and uses thereof
12/04/2014US20140356284 Hydrophobic modified peptides for liver specific diagnosis
12/04/2014US20140356282 100Mo compounds as accelerator targets for production of 99mTc
12/02/2014US8900550 Catalytic radiofluorination
12/02/2014US8900549 Compositions and methods for delivering a substance to a biological target
11/2014
11/27/2014US20140350193 Novel manganese comprising nanostructures
11/27/2014US20140348748 Beta-amyloid imaging agents, methods of manufacture, and methods of use thereof
11/27/2014US20140348747 Activation of bioluminescence by structural complementation
11/27/2014US20140348746 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof
11/27/2014US20140348745 Chimeric therapeutic anti - cd37 antibodie hh1
11/27/2014US20140348743 Monoclonal antibodies to programmed death 1 (pd-1)
11/25/2014US8895067 Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer
11/25/2014US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
11/25/2014US8894974 Radiopharmaceuticals for diagnosis and therapy
11/25/2014US8894971 Iodine radiolabelling method
11/25/2014US8894970 Arginase inhibitors and methods of use thereof
11/25/2014US8894969 Method and device for radiotherapy
11/25/2014US8894968 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
11/20/2014US20140343260 Pet/spect agents for applications in biomedical imaging
11/20/2014US20140341808 Contrast agent for imagining myocardial perfusion
11/20/2014US20140341807 Pet tracer for imaging of neuroendocrine tumors
11/20/2014US20140341805 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
11/20/2014US20140341804 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof
11/20/2014US20140341802 Provasopressin antagonists and uses thereof
11/20/2014US20140341801 Inactivation of smooth muscle tissue
11/18/2014US8889847 Antibodies and immunoconjugates and uses therefor
11/18/2014US8889142 Chlamydia trachomatis antigens for vaccine and diagnostic use
11/18/2014US8889106 Non-alcohol mouthwash composition without chemical antibacterial medicament
11/18/2014US8889100 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
11/13/2014US20140336503 Radiolabeled biomarkers for osteoclast activation and related methods thereof
11/13/2014US20140336368 Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
11/13/2014US20140335019 Compositions and methods for the treatment and analysis of neurological disorders
11/13/2014US20140335018 Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
11/13/2014US20140335017 Strontium phosphate microparticle for radiological imaging and therapy
11/13/2014US20140335016 Bacteriophage Gene 3 Protein Compositions and Use as Amyloid Binding Agents
11/13/2014US20140335015 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
11/11/2014US8883978 Antibodies to tumor endothelial marker 7R
11/11/2014US8883728 Intranasal administration of active agents to the central nervous system
11/11/2014US8883162 Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
11/11/2014US8883160 Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
11/11/2014US8883121 Oral preparation useful in measurement capacity to metabolize pyridine
11/11/2014US8883120 Polypeptides having affinity for HER2
11/06/2014US20140328757 Compositions comprising ascorbic acid and an imaging agent and related methods
11/06/2014US20140328756 Compositions, methods, and systems for the synthesis and use of imaging agents
11/06/2014US20140328755 Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders
11/06/2014US20140328754 Radioactive metal-labeled anti-cadherin antibody
11/06/2014US20140328753 Antibodies for Molecular Imaging of Vulnerable Plaques in Atherosclerosis
11/06/2014US20140328751 Antibodies that bind ov064 and methods of use therefor
11/04/2014US8877970 Inhibitors of carbonic anhydrase IX
11/04/2014US8877199 B cell surface reactive antibodies
11/04/2014US8877171 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 243